Christopher Richard
SEC-identified person · CIK 1271244 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Lexaria Corp. lxra | Director · Chief Executive Officer | filed 2024 - 2025 |
| Invivo Therapeutics Holdings Corp. None | Chief Financial Officer | filed 2019 - 2022 |
| Icad INC icad07 | Executive VP and CFO | filed 2016 - 2018 |
| Lucid INC lcdx | Chief Financial Officer | filed 2014 - 2014 |
| Dusa Pharmaceuticals INC DUSA | VP Finance & CFO | filed 2006 - 2012 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.